The growing interest in successful weight management has resulted in considerable research into groundbreaking treatments. Lately , Retatrutide, a dual -action hormone and glucagon-like peptide-1 (GLP-1) receptor activator , has shown promising results in patient trials, indicating potential for substantial weight decrease. Consequently , many indi